Tag: FDA

Pharma News

FDA Vigilance in Action: From Counterfeit Drug Dangers to Nationwide Recalls

FDA Vigilance in Action: In today’s fast-paced pharmaceutical landscape, the Food and Drug Administration (FDA) plays a crucial role in ensuring the safety and efficacy of drugs and medical devices. Here’s a roundup of the latest FDA news, covering a range of issues from counterfeit medication to recalls and patent disputes. Counterfeit Ozempic and Hospitalizations The FDA is currently investigating a series of hospitalizations linked … Continue reading FDA Vigilance in Action: From Counterfeit Drug Dangers to Nationwide Recalls

Dr. Anubhav Sharma
Xylazine: From Animal Sedative to Public Health Crisis
Science News

Xylazine: From Animal Sedative to Public Health Crisis

July 12, 2023 – In the realm of veterinary medicine, xylazine hydrochloride, approved by the FDA in 1972, has been long revered as an invaluable sedative for large animals like horses, cattle, and deer. The drug’s tranquilizing effects help calm injured or aggressive animals, allowing for their safe examination and treatment. However, the recent discovery of xylazine in illicit drug supplies has ignited a fresh … Continue reading Xylazine: From Animal Sedative to Public Health Crisis

Dr. Anubhav Sharma
Science News

FDA approves Roctavian for Gene Therapy for Hemophilia A

FDA approves Roctavian: The U.S. Food and Drug Administration (FDA) has given its stamp of approval to Roctavian, an innovative gene therapy treatment for adults suffering from severe hemophilia A without pre-existing antibodies to the adeno-associated virus serotype 5. Hemophilia A is a rare genetic bleeding disorder predominantly affecting males, brought on by a mutation in the gene responsible for producing factor VIII (FVIII), a … Continue reading FDA approves Roctavian for Gene Therapy for Hemophilia A

Dr. Anubhav Sharma
Breaking News, Science News

Urgent Recall: FDA Issues Public Health Alert for Recalled Everest and Maggi Spices Over Salmonella Risk

The U.S. Food and Drug Administration (FDA) has issued a public health alert concerning the recall of certain Everest and Maggi spices because of a potential Salmonella risk. The products under the spotlight include Everest Garam Masala, Everest Sambhar Masala, and Maggi Masala ae Magic, all of which were not labeled for distribution in the United States. Amin Trading Agency LLC, based in Edison, NJ, … Continue reading Urgent Recall: FDA Issues Public Health Alert for Recalled Everest and Maggi Spices Over Salmonella Risk

Dr. Anubhav Sharma
Pharma News

FDA Launches New Digital Health Center of Excellence

FDA Launches New Digital Health Center of Excellence- Recently, the U.S. Food and Drug Administration (FDA) unveiled a center of excellence dedicated to encouraging digital health technology development while assuring its safety and effectiveness. This effort is part of FDA’s larger push towards digital health innovation, modernizing their regulatory approach, and safeguarding public health outcomes. The DHCoE will serve as a resource to FDA staff, … Continue reading FDA Launches New Digital Health Center of Excellence

Dr. Anubhav Sharma